TipRanks
Nunzia Pharmaceutical (NUNZ)
OTHER OTC:NUNZ
US Market

Nunzia Pharmaceutical (NUNZ) Financial Statements

3 Followers

Nunzia Pharmaceutical Financial Overview

Nunzia Pharmaceutical's market cap is currently $43.46K. The company's EPS TTM is $-0.3137; its P/E ratio is ―; Nunzia Pharmaceutical is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 21Dec 20Dec 19Dec 18Dec 17
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -78.06M$ -39.33K$ -33.63K$ -27.17K$ -13.04K
EBITDA$ -77.82M$ -9.04M$ 138.22K$ -27.17K$ -13.04K
Net Income$ -78.06M$ -101.02M$ -33.63K$ -18.58K$ -13.04K
Balance Sheet
Cash & Short-Term Investments$ 131.00$ 0.00$ 0.00$ 0.00$ 0.00
Total Assets$ 5.13K$ 0.00$ 0.00$ 0.00$ 0.00
Total Debt$ 97.44K$ 23.00K$ 0.00$ 23.00K$ 23.00K
Net Debt$ -34.00$ 23.00K$ 0.00$ 23.00K$ 23.00K
Total Liabilities$ 99.31K$ 36.40K$ 22.57K$ 293.97K$ 275.39K
Stockholders' Equity$ -94.17K$ -59.40K$ -22.57K$ -293.97K$ -275.39K
Cash Flow
Free Cash Flow$ -86.78K$ -9.00M$ -3.80K$ 0.00$ 0.00
Operating Cash Flow$ -86.78K$ -9.00M$ -3.80K$ 0.00$ 0.00
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 86.91K$ 2.50K$ 3.80K$ 0.00$ 0.00
Currency in USD

Nunzia Pharmaceutical Earnings and Revenue History

Nunzia Pharmaceutical Debt to Assets

Nunzia Pharmaceutical Cash Flow

Nunzia Pharmaceutical Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.